3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
1
Breast Diseases
1
Agnosia
1
Interventions
Cyclophosphamide
955
Radiotherapy
847
Cisplatin
756
Gemcitabine
657
Carboplatin
602
Docetaxel
598
Paclitaxel
585
Bevacizumab
579
Fluorouracil
504
Oxaliplatin
458
Rituximab
453
Surveys and Questionnaires
449
Capecitabine
440
Dexamethasone
428
Doxorubicin
423
Etoposide
410
Irinotecan
389
Cytarabine
376
Filgrastim
369
pembrolizumab
327
Leucovorin
305
Nivolumab
295
fludarabine phosphate
294
Melphalan
288
Magnetic Resonance Spectroscopy
280
Blood Specimen Collection
279
Peripheral Blood Stem Cell Transplantation
278
Methotrexate
276
Lenalidomide
276
Cetuximab
269
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Codeine
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled